Rankings
▼
Calendar
INSM FY 2019 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena
INSM
Insmed Incorporated
$30B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$136M
+1287.6% YoY
Gross Profit
$112M
82.3% margin
Operating Income
-$235M
-172.4% margin
Net Income
-$254M
-186.4% margin
EPS (Diluted)
$-3.01
Cash Flow
Operating Cash Flow
-$251M
Free Cash Flow
-$293M
Stock-Based Comp.
$27M
Balance Sheet
Total Assets
$742M
Total Liabilities
$481M
Stockholders' Equity
$262M
Cash & Equivalents
$487M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$136M
$10M
+1287.6%
Gross Profit
$112M
$7M
+1414.5%
Operating Income
-$235M
-$307M
+23.5%
Net Income
-$254M
-$324M
+21.6%
← Q4 2018
All Quarters
Q1 2019 →